Style | Citing Format |
---|---|
MLA | Farzan M, et al.. "Hyaluronic Acid-Conjugated Gliadin Nanoparticles for Targeted Delivery of Usnic Acid in Breast Cancer: An in Vitro / in Vivo Translational Study." Journal of Drug Delivery Science and Technology, vol. 84, no. , 2023, pp. -. |
APA | Farzan M, Varshosaz J, Mirian M, Minaiyan M, Pezeshki A (2023). Hyaluronic Acid-Conjugated Gliadin Nanoparticles for Targeted Delivery of Usnic Acid in Breast Cancer: An in Vitro / in Vivo Translational Study. Journal of Drug Delivery Science and Technology, 84(), -. |
Chicago | Farzan M, Varshosaz J, Mirian M, Minaiyan M, Pezeshki A. "Hyaluronic Acid-Conjugated Gliadin Nanoparticles for Targeted Delivery of Usnic Acid in Breast Cancer: An in Vitro / in Vivo Translational Study." Journal of Drug Delivery Science and Technology 84, no. (2023): -. |
Harvard | Farzan M et al. (2023) 'Hyaluronic Acid-Conjugated Gliadin Nanoparticles for Targeted Delivery of Usnic Acid in Breast Cancer: An in Vitro / in Vivo Translational Study', Journal of Drug Delivery Science and Technology, 84(), pp. -. |
Vancouver | Farzan M, Varshosaz J, Mirian M, Minaiyan M, Pezeshki A. Hyaluronic Acid-Conjugated Gliadin Nanoparticles for Targeted Delivery of Usnic Acid in Breast Cancer: An in Vitro / in Vivo Translational Study. Journal of Drug Delivery Science and Technology. 2023;84():-. |
BibTex | @article{ author = {Farzan M and Varshosaz J and Mirian M and Minaiyan M and Pezeshki A}, title = {Hyaluronic Acid-Conjugated Gliadin Nanoparticles for Targeted Delivery of Usnic Acid in Breast Cancer: An in Vitro / in Vivo Translational Study}, journal = {Journal of Drug Delivery Science and Technology}, volume = {84}, number = {}, pages = {-}, year = {2023} } |
RIS | TY - JOUR AU - Farzan M AU - Varshosaz J AU - Mirian M AU - Minaiyan M AU - Pezeshki A TI - Hyaluronic Acid-Conjugated Gliadin Nanoparticles for Targeted Delivery of Usnic Acid in Breast Cancer: An in Vitro / in Vivo Translational Study JO - Journal of Drug Delivery Science and Technology VL - 84 IS - SP - EP - PY - 2023 ER - |